Found: 58
Select item for more details and to access through your institution.
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer: Safety lead‐in results from the QUATTRO-II study.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1649, doi. 10.1007/s10637-021-01125-2
- By:
- Publication type:
- Article
A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure-Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
<sup>18</sup>F-FDG-PET/CT as an imaging biomarker for regorafenib efficacy in metastatic colorectal cancer (JACCRO CC-12).
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 635, doi. 10.1007/s40487-021-00173-1
- By:
- Publication type:
- Article
Pathological Complete Response of Clinical T4b Ascending Colon Cancer after Preoperative Chemotherapy Using Pembrolizumab.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Acute Liver Failure with Diffuse Liver Metastasis from Breast Cancer, Not Detected by Computed Tomography: 2 Case Reports.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
A Complete Response Case in a Patient with Multiple Lung Metastases of Rectal Cancer Treated with Bevacizumab plus XELIRI Therapy.
- Published in:
- Case Reports in Oncology, 2017, v. 10, n. 1, p. 81, doi. 10.1159/000455899
- By:
- Publication type:
- Article
Real-World Data Analysis of Second-Line Antiangiogenic Targeted Treatments Following Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies and First-Line FOLFOX for Patients with Metastatic Colorectal Cancer.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2596, doi. 10.1007/s12325-022-02122-4
- By:
- Publication type:
- Article
Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 1, p. 180, doi. 10.1007/s10120-021-01218-0
- By:
- Publication type:
- Article
Treatment Strategy for Superficial Pharyngeal Squamous Cell Carcinoma Synchronously Combined with Esophageal Cancer.
- Published in:
- Oncology, 2012, v. 84, n. 1, p. 57, doi. 10.1159/000337981
- By:
- Publication type:
- Article
Evaluation of health-related quality of life via the Computer-Based Health Evaluation System (CHES) for Japanese metastatic breast cancer patients: a single-center pilot study.
- Published in:
- Breast Cancer (13406868), 2019, v. 26, n. 2, p. 255, doi. 10.1007/s12282-018-0905-1
- By:
- Publication type:
- Article
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Protocol of the EFFORT study: a prospective study of FOLFIRI plus aflibercept as second-line treatment after progression on FOLFOXIRI plus bevacizumab or during maintenance treatment in patients with unresectable/metastatic colorectal cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Real-world effectiveness of third- or later-line treatment in Japanese patients with HER2-positive, unresectable, recurrent or metastatic gastric cancer: a retrospective observational study.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 7, p. 1154, doi. 10.1007/s10147-022-02162-4
- By:
- Publication type:
- Article
Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 7, p. 1238, doi. 10.1007/s10147-021-01902-2
- By:
- Publication type:
- Article
Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study).
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 10, p. 1835, doi. 10.1007/s10147-020-01721-x
- By:
- Publication type:
- Article
Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study).
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 8, p. 1515, doi. 10.1007/s10147-020-01701-1
- By:
- Publication type:
- Article
Multicenter prospective phase II trial of nivolumab in patients with unresectable or metastatic mucosal melanoma.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 5, p. 972, doi. 10.1007/s10147-020-01618-9
- By:
- Publication type:
- Article
Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 7, p. 836, doi. 10.1007/s10147-019-01414-0
- By:
- Publication type:
- Article
Phase I study of primary treatment with 5-FU, oxaliplatin, irinotecan, levofolinate, and panitumumab combination chemotherapy in patients with advanced/recurrent colorectal cancer involving the wild-type <italic>RAS</italic> gene: the JACCRO CC-14 study.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 3, p. 490, doi. 10.1007/s10147-017-1228-5
- By:
- Publication type:
- Article
A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101).
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 5, p. 913, doi. 10.1007/s10147-017-1140-z
- By:
- Publication type:
- Article
Complete detection of FR1 to FR3 primer‐based PCR patterns of immunoglobulin heavy chain rearrangement in the BIOMED‐2 protocol is associated with poor prognosis in patients with diffuse large B‐cell lymphoma.
- Published in:
- EJHaem, 2024, v. 5, n. 4, p. 698, doi. 10.1002/jha2.921
- By:
- Publication type:
- Article
The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. e565, doi. 10.1093/oncolo/oyac145
- By:
- Publication type:
- Article
Hepatectomy Followed by Adjuvant Chemotherapy with 3‐Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1125, doi. 10.1002/onco.13816
- By:
- Publication type:
- Article
Phase II Study of Panitumumab Monotherapy in Chemotherapy‐Naïve Frail or Elderly Patients with Unresectable RAS Wild‐Type Colorectal Cancer: OGSG 1602.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. 17, doi. 10.1002/ONCO.13523
- By:
- Publication type:
- Article
Phase Ib/II Study of Biweekly TAS‐102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study).
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1855, doi. 10.1634/theoncologist.2020-0643
- By:
- Publication type:
- Article
Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study.
- Published in:
- Oncologist, 2018, v. 23, n. 1, p. 7, doi. 10.1634/theoncologist.2017-0275
- By:
- Publication type:
- Article
Disagreement between patient‐ and physician‐reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial
- Published in:
- Cancer Medicine, 2020, v. 9, n. 24, p. 9419, doi. 10.1002/cam4.3564
- By:
- Publication type:
- Article
Patient‐reported symptom burden as a prognostic factor in treatment with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 5, p. 1779, doi. 10.1002/cam4.2826
- By:
- Publication type:
- Article
A prospective Phase II study to examine the relationship between quality of life and adverse events of first‐line chemotherapy plus cetuximab in patients with KRAS wild‐type unresectable metastatic colorectal cancer: QUACK trial.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 9, p. 4217, doi. 10.1002/cam4.1623
- By:
- Publication type:
- Article
Case report: administration of immune checkpoint inhibitor for SMARCB1 (INI1)-negative rhabdoid carcinoma with microsatellite instability (MSI)-high in the right colon.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Real-World Data of Trifluridine/Tipiracil for Patients With Advanced Gastric Cancer: A Multi-Institutional Retrospective Study.
- Published in:
- Clinical Medicine Insights: Oncology, 2022, p. 1, doi. 10.1177/11795549221137135
- By:
- Publication type:
- Article
Treatment sequences of patients with advanced colorectal cancer and use of second-line FOLFIRI with antiangiogenic drugs in Japan: A retrospective observational study using an administrative database.
- Published in:
- PLoS ONE, 2021, v. 16, n. 2, p. 1, doi. 10.1371/journal.pone.0246160
- By:
- Publication type:
- Article
Regorafenib vs trifluridine/tipiracil for metastatic colorectal cancer refractory to standard chemotherapies: A multicenter retrospective comparison study in Japan.
- Published in:
- PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0234314
- By:
- Publication type:
- Article
Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prevalence and risk factors of hepatitis B virus reactivation in patients with solid tumors with resolved HBV infection.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 1, p. 63, doi. 10.1111/ajco.13050
- By:
- Publication type:
- Article
Role of plasma angiogenesis factors in the efficacy of first‐line chemotherapy combined with biologics in RAS wild‐type metastatic colorectal cancer: Results from the GI‐SCREEN CRC‐Ukit study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 18, p. 18702, doi. 10.1002/cam4.6486
- By:
- Publication type:
- Article
Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50026-4
- By:
- Publication type:
- Article
Early Clinical Outcomes of Anal Squamous Cell Carcinoma Treated with Concurrent Chemoradiotherapy with 5-Fluorouracil Plus Mitomycin C in Japanese Patients: Experience at a Single Institution.
- Published in:
- Japanese Journal of Clinical Oncology, 2012, v. 42, n. 9, p. 861, doi. 10.1093/jjco/hys093
- By:
- Publication type:
- Article
Survival impact of microsatellite instability in stage II gastric cancer patients who received S-1 adjuvant monotherapy after curative resection.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-37870-y
- By:
- Publication type:
- Article
Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 221, doi. 10.1093/jjco/hyac188
- By:
- Publication type:
- Article
Germline variants in cancer-predisposing genes in pancreatic cancer patients with a family history of cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 10, p. 1105, doi. 10.1093/jjco/hyac110
- By:
- Publication type:
- Article
Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Correction to: A placebo‑controlled, double‑blind, randomized study of recombinant thrombomodulin (ART‑123) to prevent oxaliplatin‑induced peripheral neuropathy.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Phase 1 study of Gemcitabine/Nab-paclitaxel/S-1 in patients with unresectable pancreatic cancer (GeNeS1S trial).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 1, p. 65, doi. 10.1007/s00280-020-04174-1
- By:
- Publication type:
- Article
A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 5, p. 607, doi. 10.1007/s00280-020-04135-8
- By:
- Publication type:
- Article
Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Multicenter phase II study of SOX plus trastuzumab for patients with HER2<sup>+</sup> metastatic or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS 1501B.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane.
- Published in:
- 2018
- By:
- Publication type:
- journal article